1-6 of 6
glycosuria
Close
Sort by
Journal Articles

Renal Safety after More Than a Decade of Deferasirox Use in Patients with Transfusional Hemosiderosis

Raffaella Origa, Antonio Piga, MD, Immacolata Tartaglione, MD, Giuseppina Della Corte, Ali El-Ali, Jackie Han, Chiara Castiglioni, Gian Luca Forni, MD
Journal: Blood
Blood (2016) 128 (22): 2466.
https://doi.org/10.1182/blood.V128.22.2466.2466
Published: 2016
Journal Articles

Children with Thalassemia Major Display Abnormal Renal Tubular Function

Maria Paola Boaro, Giada Biddeci, Elena Varotto, Giulia Geranio, Valderza Beqiri, Giuseppe Basso, Maria Ludovica Frizziero, Enrico Vidal, Maria Caterina Putti, MD
Journal: Blood
Blood (2016) 128 (22): 3628.
https://doi.org/10.1182/blood.V128.22.3628.3628
Published: 2016
Journal Articles

Efficacy and Safety of Deferasirox (Exjade®) in Patients with β-Thalassemia Major Treated for up to 5 Years.

M. Domenica Cappellini, Silverio Perrotta, Leyla Agaoglu, Yesim Aydinok, Marcello Capra, Duran Canatan, Guillermo Drelichman, Yurdanur Kilinc, Carmelo Magnano, John B. Porter, Antonio Piga, Louis Griffel, Darlene Lagrone, Joan Clark, Antonis Kattamis
Journal: Blood
Blood (2009) 114 (22): 4063.
https://doi.org/10.1182/blood.V114.22.4063.4063
Published: 2009
Journal Articles

Efficacy and Safety of Deferasirox (Exjade ® ) with up to 4.5 Years of Treatment in Patients with Thalassemia Major: A Pooled Analysis

Maria Domenica Cappellini, Renzo Galanello, Antonio Piga, Alan Cohen, Antonis Kattamis, Yesim Aydinok, Paul Williamson, Lisa Rojkjaer, John B Porter
Journal: Blood
Blood (2008) 112 (11): 5411.
https://doi.org/10.1182/blood.V112.11.5411.5411
Published: 2008
Journal Articles

Deferasirox (Exjade ® ) in Pediatric Patients with β-Thalassemia: Update of 4.7-Year Efficacy and Safety from Extension Studies

Antonio Piga, Gian Luca Forni, Antonis Kattamis, Christos Kattamis, Yesim Aydinok, Martha Rodriguez, Lisa Rojkjaer, Renzo Galanello
Journal: Blood
Blood (2008) 112 (11): 3883.
https://doi.org/10.1182/blood.V112.11.3883.3883
Published: 2008
Journal Articles

Reversal of New-Onset Type 1 Diabetes in Mice and Induction of FoxP3+ Regulatory T Cells by Syngeneic Bone Marrow Transplantation.

Jian Ouyang, MD, Yanting Wen, MD, Junhao Chen, Yong Liu, De Pei Wu, MD
Journal: Blood
Blood (2007) 110 (11): 4857.
https://doi.org/10.1182/blood.V110.11.4857.4857
Published: 2007